These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31377969)

  • 41. Antiproliferative effect of chrysin on anaplastic thyroid cancer.
    Phan T; Yu XM; Kunnimalaiyaan M; Chen H
    J Surg Res; 2011 Sep; 170(1):84-8. PubMed ID: 21571321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An in vivo mouse model of metastatic human thyroid cancer.
    Zhang L; Gaskins K; Yu Z; Xiong Y; Merino MJ; Kebebew E
    Thyroid; 2014 Apr; 24(4):695-704. PubMed ID: 24262022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of p21 and Akt potentiates SU6656-induced caspase-independent cell death in FRO anaplastic thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Horm Metab Res; 2013 Jun; 45(6):408-14. PubMed ID: 23386415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.
    Poulaki V; Mitsiades CS; Kotoula V; Tseleni-Balafouta S; Ashkenazi A; Koutras DA; Mitsiades N
    Am J Pathol; 2002 Aug; 161(2):643-54. PubMed ID: 12163389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of vemurafenib-induced anti-tumor effects in ATC FRO cells.
    Xu J; Xue D; Li Y; Zhou J; Chen H; Fan L
    Heliyon; 2024 Mar; 10(6):e27629. PubMed ID: 38509927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma.
    Wang Z; Qiu X; Zhang H; Li W
    J Biochem Mol Toxicol; 2020 May; 34(5):e22469. PubMed ID: 32173973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.
    Kocdor MA; Cengiz H; Ates H; Kocdor H
    Anticancer Agents Med Chem; 2019; 19(15):1887-1898. PubMed ID: 31584382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model.
    Danysh BP; Rieger EY; Sinha DK; Evers CV; Cote GJ; Cabanillas ME; Hofmann MC
    Oncotarget; 2016 May; 7(21):30907-23. PubMed ID: 27127178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
    Zhang K; Yu M; Hao F; Dong A; Chen D
    Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression.
    Wang SH; Mezosi E; Wolf JM; Cao Z; Utsugi S; Gauger PG; Doherty GM; Baker JR
    Oncogene; 2004 Jan; 23(4):928-35. PubMed ID: 14647456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Dihydrotanshinone I on Proliferation and Invasiveness of Paclitaxel-Resistant Anaplastic Thyroid Cancer Cells.
    Allegri L; Capriglione F; Maggisano V; Damante G; Baldan F
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.
    Duquette M; Sadow PM; Husain A; Sims JN; Antonello ZA; Fischer AH; Song C; Castellanos-Rizaldos E; Makrigiorgos GM; Kurebayashi J; Nose V; Van Hummelen P; Bronson RT; Vinco M; Giordano TJ; Dias-Santagata D; Pandolfi PP; Nucera C
    Oncotarget; 2015 Dec; 6(40):42445-67. PubMed ID: 26636651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting TGF-β1 and AKT signal on growth and metastasis of anaplastic thyroid cancer cell in vivo.
    Li Y; Chen D; Hao FY; Zhang KJ
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2581-7. PubMed ID: 27383308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status.
    Ishihara S; Onoda N; Noda S; Asano Y; Tauchi Y; Morisaki T; Kashiwagi S; Takashima T; Ohira M
    Int J Oncol; 2019 Nov; 55(5):1069-1076. PubMed ID: 31545405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2-methoxyestradiol induces apoptosis in cultured human anaplastic thyroid carcinoma cells.
    Roswall P; Bu S; Rubin K; Landström M; Heldin NE
    Thyroid; 2006 Feb; 16(2):143-50. PubMed ID: 16676399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation.
    Ayroldi E; Petrillo MG; Marchetti MC; Cannarile L; Ronchetti S; Ricci E; Cari L; Avenia N; Moretti S; Puxeddu E; Riccardi C
    Cell Death Dis; 2018 Feb; 9(3):305. PubMed ID: 29467389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells.
    Du ZX; Wang HQ; Zhang HY; Gao DX
    Endocrinology; 2007 Sep; 148(9):4352-61. PubMed ID: 17540725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer.
    Mitsiades CS; Poulaki V; Mitsiades N
    J Endocrinol; 2003 Aug; 178(2):205-16. PubMed ID: 12904168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
    Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
    J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells.
    Mio C; Conzatti K; Baldan F; Allegri L; Sponziello M; Rosignolo F; Russo D; Filetti S; Damante G
    Oncol Rep; 2018 Feb; 39(2):582-588. PubMed ID: 29251329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.